A new 8-month study showed that TocovidTM SupraBioTM 50mg oral supplementation
promotes hair growth in both men and women suffering from androgenetic alopecia
Pattern baldness condition is said to affect about 50 percent of men and women over the
age of 40, and is said to be caused by three independent factors, testosterone levels,
genetic disposition and advancing age.
28 volunteers with mild to moderately severe ongoing hair loss completed the 8-month
study conducted at the School of Pharmaceutical Science, Universiti Sains Malaysia.
The volunteers receive the TocovidTM SupraBioTM 50mg or placebo, administrated twice
daily. Hair counts and weight of hair in pre-selected evaluation area were measured
before and after every month initiation of the study.
An average of 41.8% increase in the number of hair was observed after 8-month tocotrienol
· 8 volunteers (40%) showed > 50% hair growth
· 1 volunteer (5%) showed > 25-50% hair growth
· 9 volunteers (45%) showed > 10-25% hair growth
· 1 volunteer (5%) showed > 10% hair growth
The unique of the TocominTM SupraBioTM system provide 250% increase in absorption of tocotrienols, hence to achieve therapeutic levels in the bloodstream at a lower dosage of the
supplementation. It promotes the absorption of tocotrienols via the lymphatic system, whereas it does not depend on dietary fact or food intake. Plus, it allows consistent and rapid
transport of tocotrienols into the blood thus the maximum peak is reached much quicker.
The formulation is a natural full spectrum palm tocotrienol complex that is a more potent form Vitamin E with unique health benefits, which not only has shown good results in the treatment of pattern baldness; tocotrienols come in both natural and synthetic forms and are also to reduce the effect of free radicals, with studies pinpointing that this property gives the compound an anti-cancer effect, maintain healthy cholesterol level and prevent cardiovascular disease.